Toronto, Aug. 27, 2026 (GLOBE NEWSWIRE) — Low-rise new home sales in the Greater Toronto Area (GTA) continue to benefit from increased demand following the introduction of the HST rebate program, outperforming its 10-year average for a fourth consecutive month in July, the Building Industry and Land Development Association (BILD) said today. Conversely, the condominium sector has continued to struggle to fully participate in the HST rebate program as rules around construction start and completion dates limit this segment of the market.
Low-rise new home sales in the GTA continue to reap the benefits of the HST rebate program in July
Toronto, Aug. 27, 2026 (GLOBE NEWSWIRE) — Low-rise new home sales in the Greater Toronto Area (GTA) continue to benefit from increased demand following the introduction of the HST rebate program, outperforming its 10-year average for a fourth consecutive month in July, the Building Industry and Land Development Association (BILD) said today. Conversely, the condominium sector has continued to struggle to fully participate in the HST rebate program as rules around construction start and completion dates limit this segment of the market.
Four Goranson Bain Ausley Attorneys Named 2027 Best Lawyers® “Lawyer of the Year”
Goranson Bain Ausley (GBA) announced that four of its attorneys have been named 2027 Best Lawyers® “Lawyer of the Year,” with recognition spanning Family Law, Collaborative Law: Family Law and Family Law Mediation in Austin and Dallas/Fort Worth.
Rupert Grint to Reprise Film Role of “Ron Weasley” in Harry Potter and the Cursed Child on Broadway in New York City
Limited Engagement Beginning Tuesday, February 2, 2027 at New York City's Lyric Theatre
HighLife Receives CE Mark Approval for Clarity Valve, the Next-Generation Valve for the HighLife TMVR System
Transferra Backs John Galt Forum, with COO Alexey Reshko Joining the Panel Discussion
London, UK, Aug. 27, 2026 (GLOBE NEWSWIRE) — Transferra, a UK FCA-authorised electronic money institution, has announced its sponsorship of the John Galt Forum, taking place on 7 October 2026 at the Digital Art House in Riga.
Harmovest Capital Strengthens Global Financial Services Through Technology and Compliance
LIMASSOL, Cyprus, Aug. 27, 2026 (GLOBE NEWSWIRE) — Harmovest Capital today announced the continued development of its global financial services platform, bringing together technology, international market access, compliance and professional services within an integrated financial ecosystem. The initiative reflects the company’s focus on supporting clients and professional partners across regional markets while strengthening its capabilities in an increasingly interconnected financial landscape.
Osivax and GC Biopharma Enter Strategic Collaboration to Develop a Next-Generation Influenza Vaccine Combining OVX836 and GC FLU
Lyon, France and Yongin, Republic of Korea – 27 August 2026 – Osivax, a clinical-stage biopharmaceutical company developing differentiated influenza vaccines designed to generate broad-spectrum immune responses, and GC Biopharma, a leading South Korean biopharmaceutical company with extensive experience in vaccines and plasma-derived products, today announced a long-term collaboration to develop and commercialize a next-generation seasonal influenza vaccine candidate designed to provide broader and more durable protection against a wide range of influenza strains.
Elden leder stipendiatens tecknande
Uppsala, Aug. 27, 2026 (GLOBE NEWSWIRE) —
Sebastian Blind Passage Bror Hjorthföreningens teckningsstipendiat 2026 5 september – 4 oktober 2026 Bror Hjorths Hus, Uppsala
S-Pankki Oyj on saanut tarvittavan kilpailuviranomaisen hyväksynnän kaikista Oma Säästöpankki Oyj:n osakkeista tehdylle vapaaehtoiselle julkiselle käteisostotarjoukselle
EI JULKISTETTAVAKSI TAI LEVITETTÄVÄKSI, KOKONAAN TAI OSITTAIN, SUORAAN TAI VÄLILLISESTI, AUSTRALIASSA, KANADASSA, HONGKONGISSA, JAPANISSA, UUDESSA-SEELANNISSA TAI ETELÄ-AFRIKASSA TAI NÄIHIN MAIHIN TAI MILLÄÄN MUULLA ALUEELLA TAI MILLEKÄÄN MUULLE ALUEELLE, JOSSA OSTOTARJOUS OLISI SOVELTUVAN LAIN VASTAINEN. LISÄTIETOJA ALLA KOHDASSA ”TÄRKEÄÄ TIETOA”.
S-Bank Plc has received required merger control clearance for its voluntary public cash tender offer for all the shares in Oma Savings Bank Plc
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. FOR FURTHER INFORMATION, PLEASE SEE SECTION ENTITLED “IMPORTANT INFORMATION” BELOW.
hVIVO acquires CRS Berlin, expanding expertise into dermatology and women’s health markets
London, UK – 27 August 2026, hVIVO plc (AIM: HVO), a purpose-built, full-service international clinical development partner and the world leader in human challenge trials, announces the acquisition of CRS Clinical Research Services Berlin GmbH (“CRS Berlin”).
Nicox Announces April 2027 PDUFA Date for NCX 470 in Glaucoma
1 A PDUFA date is the target date by which the U.S. Food and Drug Administration (FDA) aims to complete its review and issue a decision on a New Drug Application (NDA) under the Prescription Drug User Fee Act (PDUFA).
Nicox annonce avril 2027 comme date PDUFA pour NCX 470 dans le traitement du glaucome
1 La date PDUFA correspond à la date cible à laquelle la Food and Drug Administration (FDA) américaine prévoit d’achever la revue d’une demande d’autorisation de mise sur le marché (NDA) et de rendre sa décision, conformément au Prescription Durg User Fee Act (PDUFA).